1,545
Views
10
CrossRef citations to date
0
Altmetric
Articles; Pharmaceutical Biotechnology

In vitro evaluation of antioxidant and neuroprotective effects of curcumin loaded in Pluronic micelles

, , , , , & show all
Pages 991-997 | Received 24 Mar 2016, Accepted 03 May 2016, Published online: 16 Jun 2016

References

  • Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Delivery Rev. 2001;47:113–131.
  • Yoncheva K, Calleja P, Agueros M, et al. Stabilized micelles as delivery vehicles for paclitaxel. Int J Pharm. 2012;436:258–264.
  • Zhao Y, Li Y, Ge J, et al. Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel. Drug Dev Ind Pharm. 2014;40:1483–1493.
  • Zhang ZH, Abbad S, Pan RR, et al. N-octyl-N-arginine chitosan micelles as an oral delivery system of insulin. J Biomed Nanotechnol. 2013;9:601–609.
  • Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–818.
  • Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75:787–809.
  • Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–356.
  • Bisht S, Mizuma M, Feldmann G, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc™) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010;9:2255–2264.
  • Naksuriya O, Okonogi S, Schiffelers R, et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35:3365–3383.
  • Leung MH, Colangelo H, Kee TW. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir. 2008;24:5672–5675.
  • Zhao L, Du J, Duan Y, et al. Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Coll Surf B: Biointerfaces. 2012;97:101–108.
  • Liang J, Wu W, Lai D, et al. Enhanced solubility and targeted delivery of curcumin by lipopeptide micelles. J Biomater Sci Polymer Ed. 2015;26:369–383.
  • Yoncheva K, Kamenova K, Perperieva T, et al. Cationic triblock copolymer micelles enhance antioxidant activity, intracellular uptake and cytotoxicity of curcumin. Int J Pharm. 2015;490:298–307.
  • Kabanov A, Batrakova EV, Melik-Nubarov NS, et al. A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J Contr Rel. 1992;22:141–157.
  • Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
  • Mansuy D, Sassi A, Dansette PM, et al. A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiol thione. Biochem Biophys. 1986;135:1021–1051.
  • Deby C, Goutier R. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Biochem Pharmacol. 1990;39:399–405.3
  • Taupin P, Zini S, Cesselin F, et al. Subcellular fractionation on Percoll gradient of mossy fiber synaptosomes: morphological and biochemical characterization in control and degranulated rat hippocampus. J Neurochem. 1994;62:1586–1595.
  • Robyt JF, Ackerman RJ, Chittenden CG. Reaction of protein disulfide groups with Ellman's reagent: a case study of the number of sulfhydryl and disulfide groups in Aspergillusoryzae – amylase, papain, and lysosome. Arch Biochem Biophys. 1971;147:262–269.
  • Mungarro-Menchaca X, Ferrera P, Moran J, et al. Beta-amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J Neurosci Res. 2002;68:89–96.
  • Chen F, Rice KC, Liu XM, et al. Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm. Pharm Res. 2010;27:2356–2364.
  • Pepic I, Lovric J, Hafner A, et al. Powder form and stability of Pluronic mixed micelle dispersions for drug delivery applications. Drug Dev Ind Pharm. 2014;40:944–951.
  • Sahu A, Kasoju N, Goswami P, et al. Encapsulation of curcumin in pluronic block copolymer micelles for drug delivery applications. J Biomater Appl. 2011;25:619–639.
  • Chiappetta DA, Hocht C, Taira C, et al. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailaibility. Nanomed. 2010;5:11–23.
  • Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B. 1999;16:3–27.
  • Basak R, Bandyopadhyay R. Encapsulation of hydrophobic drugs in Pluronic F127 micelles: effects of drug hydrophobicity, solution temperature, and pH. Langmuir. 2013;29:4350–4356.
  • Ishrat T, Hoda MN, Khan MB, et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharmacol. 2009;19:636–647.
  • Bisht K, Wagner KH, Bulmer AC. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology. 2010;278:88–100.
  • Reddy AC, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Chem Biochem. 1992;111:117–124.
  • Zaidi SI, Agarwal R, Eichler G, et al. Photodynamic effects of new silicon phthalocyanines: in vitro studies utilizing rat hepatic microsomes and human erythrocyte ghosts as model membrane sources. Photochem Photobiol. 1993;58:204–210.
  • Barzegar AA, Moosavi-Movahedi A. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS ONE [Internet]. 2011 [cited 2016 Apr 14];6:e26012. Available from: http://dx.doi.org/10.1371/journal.pone.0026012
  • Trujillo J, Chirino YI, Molina-Jijon E, et al. Renoprotective effect of the antioxidant curcumin: recent findings. Redox Biol. 2013;1:1–9.
  • Blandini F, Armentero MT, Martignoni E. The 6-hydroxydopamine model: news from the past. Parkisonism Relat Disord. 2008;14:S124–S129.
  • Stokes AH, Freeman WM, Mitchell SG, et al. Induction of GADD45 and GADD153 in neuroblastoma cells by dopamine-induced toxicity. Neurotoxicology. 2002;23:675–684.
  • Yoncheva K, Kondeva-Burdina M, Tzankova V, et al. Curcumin delivery from poly(acrylic acid-co-methylmethacrylate) hollow microparticles prevents dopamine-induced toxicity in rat brain synaptosomes. Int J Pharm. 2015;486:259–267.